Vimarsana
Biggest News Aggregation in the World

Page 36 - Lanham Act News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lanham Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lanham Act Today - Breaking & Trending Today

Travis Kelce's Trademarks Era: A Celebrity Marks Spotlight | Dunlap Bennett & Ludwig PLLC - Vimarsana News

Travis Kelce's Trademarks Era: A Celebrity Marks Spotlight | Dunlap Bennett & Ludwig PLLC

Think about some of your favorite brands, and how each is recognized. Everyone knows what a WHOPPER is and who sells it. A very particular shade of blue has been associated with TIFFANY...

Trick and Treat: File Fraudulent Declaration and Retain Trademark Registration  | Irwin IP LLP - Vimarsana News

Trick and Treat: File Fraudulent Declaration and Retain Trademark Registration  | Irwin IP LLP

Great Concepts, LLC v. Chutter, Inc., No. 22-1212 (Fed. Cir. Oct. 18, 2023) - Challenging years of perceived overreach, the Court of Appeals for the Federal Circuit...

NATERA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Natera, Inc. - NTRA -November 03, 2023 at 10:51 pm EDT - Vimarsana News

NATERA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Natera, Inc. - NTRA -November 03, 2023 at 10:51 pm EDT

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has commenced an investigation into Natera, Inc. . On...

Pacira BioSciences, Inc. (NASDAQ:PCRX) Q3 2023 Earnings Call Transcript - Vimarsana News

Pacira BioSciences, Inc. (NASDAQ:PCRX) Q3 2023 Earnings Call Transcript

Pacira BioSciences, Inc. (NASDAQ:PCRX) Q3 2023 Earnings Call Transcript November 2, 2023 Pacira BioSciences, Inc. misses on earnings expectations. Reported EPS is $0.72 EPS, expectations were $0.84. Operator: Good day, and thank you for standing by. Welcome to the Q3 2023 Pacira BioSciences Earnings Conference Call. At this time, all participants are in a listen-only […]

Source: yahoo.com
MarkIt to Market® - October 2023: A Limit to Cancel Culture? Federal Circuit Finds Fraud in Connection with Section 15 Declaration of Incontestability Not a Cancellable Offense | Sterne, Kessler, Goldstein & Fox P.L.L.C. - Vimarsana News

MarkIt to Market® - October 2023: A Limit to Cancel Culture? Federal Circuit Finds Fraud in Connection with Section 15 Declaration of Incontestability Not a Cancellable Offense | Sterne, Kessler, Goldstein & Fox P.L.L.C.

In 2021, the Trademark Trial and Appeal Board cancelled Great Concepts, LLC’s trademark registration for the mark DANTANNA’S for restaurant services under Section 14, after finding that...